Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGUNIGALSIDASE ALFA-IWXJ: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

41.4%
Female
58.6%
Male

Age Information

The average age of patients reporting adverse events with PEGUNIGALSIDASE ALFA-IWXJ is 40.4 years.

Geographic Distribution

The majority of adverse event reports for PEGUNIGALSIDASE ALFA-IWXJ originate from US.

Report Summary & Outcomes

202
Total Reports
202
As Primary/Secondary Suspect
3
Deaths Reported
43
Hospitalizations
2
Life-Threatening
2
Disabilities

Reporting Timeline

First adverse event report: 20221101. Most recent report: 20250906. View full timeline →

More About PEGUNIGALSIDASE ALFA-IWXJ

PEGUNIGALSIDASE ALFA-IWXJ Full Profile Reports by Year Drug Interactions